By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Illumina has scheduled its annual shareholders meeting for April 18, during which the fate of Roche's $5.7 billion hostile bid for Illumina could be determined.
Registering provides access to this and other free content.
Already have an account?Login Now.
Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.
The Kansas City Star examines issues surrounding newborn genome sequencing.
Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.
In Science this week: the Human Silencing Hub protein complex, and more.